PAC/NP-IN-1
PAC/NP-IN-1 (Compound 30) is a dual-target anti-influenza agent that specifically binds to nucleoprotein (NP) and the C-terminal domain of PA protein (PAc) . PAC/NP-IN-1 inhibits influenza A virus A/WSN/33 (H1N1) (EC50 = 3.63 μM, IC50 = 3.08 μM) . PAC/NP-IN-1 can be used for the study of influenza infection[1].
Product Specifications
UNSPSC
12352005
Target
Influenza Virus
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=C(NC2=NC=NC3=CC=CC=C32)C=CC=C1)NCCN4CCN(C5=C(C)C=C(C)C=C5)CC4
Molecular Formula
C29H32N6O
Molecular Weight
480.60
References & Citations
[1]Zhang C, et al. Quinazoline-based dual-target inhibitors disrupt influenza virus RNP complex: Rational design, synthesis and mechanistic validation of potent anti-influenza agents. Eur J Med Chem. 2025 Sep 21;301:118185.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940096-500 1x 500 µL
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400158-500 1x 500 µL
Cytokeratin 17 (E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470266-100 1x 100 µL
Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400276-500 1x 500 µL
TAG-72 / CA72.4 (B72.3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470049-100 1x 100 µL
CD31 / PECAM-1 (C31.3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882990-500 1x 500 µL
CD63 (Late Endosomes Marker) (LAMP3/2990R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details